Community Healthcare Trust
Community Healthcare Trust's revenue rose 4.7% to $121 million in fiscal 2025. Its net margin was 4.2%, up from −2.8% a year earlier. Free cash flow was $36 million, up 4.9%. It paid out $54 million in dividends and buybacks, 149% of free cash flow. The diluted share count rose 1.2%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Community Healthcare Trust does
Community Healthcare Trust is a real estate investment trust (REIT) that owns and buys properties leased to hospitals, doctors, healthcare systems and other healthcare providers. Its portfolio includes medical office buildings, inpatient rehabilitation facilities, behavioral health facilities, specialty centers, physician clinics and surgical centers.
It earns money from rent. At December 31, 2025, it had gross investments of about $1.2 billion in 198 properties in 36 states, with a weighted average remaining lease term of about 7.0 years. Excluding one property held for sale, they were about 90.6% leased.
No tenant provided more than 10% of its annualized rent. Its tenants include nationally recognized healthcare providers such as Hospital Corporation of America, DaVita and Tenet Healthcare.
Its biggest risks, as it describes them
- Its investments are concentrated in healthcare properties.
- Major tenants failing to pay rent because their finances worsen.
- Difficulty finding replacement tenants if leases end or tenants default.
- Being unable to find or complete property acquisitions that drive its growth.
- Dependence on its senior management and other key employees.
Income statement
From fiscal 2016 to 2025, earnings per share fell 11.5% a year and net income grew 7.3% a year, as new shares raised the share count by 138% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 2 | 11 | 4 | 4 | 3 |
| Debt incl. finance leases | 269 | 356 | 406 | 489 | 535 |
| Net debt (negative means net cash) | 266 | 345 | 403 | 485 | 532 |
| Net debt to EBITDA | 3.6x | 5.2x | 6.1x | 7.6x | 7.0x |
| Debt to equity | 0.6x | 0.7x | 0.8x | 1.0x | 1.2x |
| Interest coverage | 4.1x | 2.9x | 1.5x | 0.9x | 1.2x |
| Current ratio | — | — | — | — | — |
| Quick ratio | — | — | — | — | — |
Cash flow
Projections
Project Community Healthcare Trust's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 2 insiders bought $272,980 of Community Healthcare Trust shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | David H. DupuyCEO and President, Director | Bought | 10,000 | $15.13 | $151,300 | Form 4 |
| Aug 11, 2026 | Robert Z HensleyDirector | Bought | 8,000 | $15.21 | $121,680 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 53.1% | 32.2% | 34.3% |
| Altman Z'' | — | — | — |
| Accruals ratio | −5.9% | −6.4% | −5.2% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Fail | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | — | — | — |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | — | — | — |
Compare
Put Community Healthcare Trust side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Community Healthcare Trust | FY25 | 4.7% | — | 29.6% | 3.2% | 7.0x | — | |
| Universal Health Realty Income Trust | FY25 | 0.2% | 35.0% | — | 5.2% | 5.8x | — | Compare |
| Chiron Real Estate | FY25 | 6.8% | — | — | — | — | — | Compare |
| Strawberry Fields REIT | FY25 | 32.4% | 54.4% | — | 8.8% | 5.8x | — | Compare |
| LTC Properties | FY25 | 25.3% | 77.9% | 49.0% | 11.0% | 3.4x | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 25 | 37 | 49 | 61 | 76 | 91 | 98 | 113 | 116 | 121 |
| Revenue growth | — | 47.9% | 30.3% | 25.3% | 24.4% | 19.7% | 7.8% | 15.5% | 2.6% | 4.7% |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — | — |
| Net income | 3 | 4 | 4 | 8 | 19 | 22 | 22 | 8 | −3 | 5 |
| Diluted EPS (US$) | 0.24 | 0.19 | 0.19 | 0.37 | 0.80 | 0.87 | 0.81 | 0.20 | −0.23 | 0.08 |
| Diluted shares (millions) | 11 | 15 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 27 |
| Cash flow | ||||||||||
| Cash from operations | 15 | 22 | 24 | 32 | 48 | 56 | 60 | 61 | 59 | 56 |
| Capital expenditure | 2 | 1 | 5 | 4 | 7 | 7 | 10 | 19 | 25 | 20 |
| Free cash flow | 13 | 21 | 20 | 28 | 41 | 49 | 50 | 42 | 34 | 36 |
| Dividends paid | 18 | 24 | 29 | 32 | 38 | 42 | 44 | 48 | 52 | 54 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 104 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 1 | 2 | 3 | 4 | 5 | 7 | 9 | 8 | 10 | 10 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 2 | 2 | 2 | 2 | 2 | 2 | 11 | 4 | 4 | 3 |
| Debt incl. finance leases | 51 | 93 | 148 | 194 | 212 | 269 | 356 | 406 | 489 | 535 |
| Total assets | 252 | 386 | 427 | 562 | 668 | 754 | 876 | 945 | 993 | 991 |
| Total liabilities | 58 | 102 | 155 | 209 | 238 | 292 | 380 | 432 | 517 | 561 |
| Shareholders' equity | 194 | 283 | 272 | 353 | 430 | 462 | 497 | 513 | 476 | 429 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — |
| Net margin | 10.8% | 9.4% | 9.1% | 13.8% | 25.2% | 24.8% | 22.5% | 6.8% | −2.8% | 4.2% |
| Free cash flow margin | 53.0% | 56.3% | 41.0% | 46.0% | 54.7% | 54.2% | 51.1% | 37.6% | 29.6% | 29.6% |
| Rule of 40 (growth + FCF margin) | — | 104.3% | 71.2% | 71.3% | 79.0% | 73.9% | 58.9% | 53.1% | 32.2% | 34.3% |
| Return on capital | — | 3.5% | 5.0% | 5.3% | 6.1% | 6.3% | 4.3% | 2.8% | 1.7% | 3.2% |
| Return on equity | 1.7% | 1.5% | 1.6% | 2.7% | 4.9% | 5.0% | 4.6% | 1.5% | −0.6% | 1.1% |
| Return on assets | 1.4% | 1.1% | 1.1% | 1.7% | 3.1% | 3.2% | 2.7% | 0.8% | −0.3% | 0.5% |
| Net debt to EBITDA | 2.7x | 3.2x | 3.7x | 3.8x | 3.4x | 3.6x | 5.2x | 6.1x | 7.6x | 7.0x |